Navigation Links
China Biologic to Participate in Upcoming Investor Conferences
Date:8/29/2013

BEIJING, Aug. 29, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, is scheduled to participate in the upcoming conferences:

  • Credit Suisse Asian Healthcare Conference, to be held September 3, 2013 at the Credit Suisse office at International Commerce Centre, Hong Kong. Management is scheduled to meet with institutional investors throughout Tuesday, September 3.
  • Morgan Stanley Global Healthcare Conference, to be held September 9-11, 2013 at the Grand Hyatt New York. Management is scheduled to meet with institutional investors throughout the event.

For additional information, please contact the respective institutional sales representative at each sponsoring bank.

About China Biologic Products, Inc.

China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in China. For additional information, please see the Company's website www.chinabiologic.com.

Contact:

China Biologic Products, Inc.
Mr. Ming Yin
Vice President 
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com

ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: bill.zima@icrinc.com


'/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
2. MEDTEC China 2013: Conference Program Closes in on Finalization
3. China Orthopedic Devices Market, Contract Manufacturing in Orthopedic Industry Reports
4. China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2014 First Quarter Earnings Results and Schedules Conference Call for August 19, 2013
5. Chinas Strong Economic Growth and Healthcare Investments Generate Success for CPhI
6. Chinas Type 2 Diabetes Market Will Grow To $3.5 Billion In 2017
7. China Nepstar Chain Drugstore Ltd. to Report Second Quarter 2013 Financial Results
8. China is an Attractive Option for Pharmaceutical Outsourcing due to Low Development Costs
9. China Biologic Reports Financial Results for the Second Quarter and First Half of 2013
10. BD and the College of American Pathologists Announce Strategic Alliance to Support Laboratory Quality and Performance in India and China
11. China Biologic Products to Report Second Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
Breaking Medicine News(10 mins):